WallStreetZenWallStreetZen

NASDAQ: AQST
Aquestive Therapeutics Inc Stock Ownership - Who owns Aquestive Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Aquestive Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Peter E. BoydSVP IT HR Communications2025-09-0515,000$5.30
$79.50kSell
Cassie JungChief Operating Officer2025-09-0425,000$3.15
$78.75kBuy
Cassie JungChief Operating Officer2025-09-0462,180$5.00
$310.90kSell
Cassie JungChief Operating Officer2025-09-0425,000$0.71
$17.65kBuy
Carl N. KrausChief Medical Officer2025-08-0910,819$3.90
$42.19kSell
Sherry KorczynskiSVP Sales and Marketing2025-06-092,714$3.54
$9.61kSell
Stephen WargackiChief Science Officer2025-03-104,572$2.54
$11.61kSell
Cassie JungChief Operating Officer2025-03-102,182$2.54
$5.54kSell
Peter E. BoydSVP Information Technology Human Resources and Communications2025-03-097,681$2.65
$20.35kSell
Daniel BarberPresident and CEO2025-03-0953,998$2.65
$143.09kSell

1 of 3

AQST insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AQST insiders and whales buy or sell their stock.

AQST Shareholders

What type of owners hold Aquestive Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bratton Capital Management LP9.84%9,810,958$48.56MInstitution
Blackrock Inc6.49%6,476,606$32.06MInstitution
Vanguard Group Inc4.34%4,328,505$21.43MInstitution
Millennium Management LLC2.99%2,979,840$14.75MInstitution
Perceptive Advisors LLC2.20%2,190,420$10.84MInstitution
Geode Capital Management LLC1.98%1,977,001$9.79MInstitution
Douglas K. Bratton1.97%1,963,890$9.72MInsider
Pale Fire Capital Se1.68%1,676,451$8.30MInstitution
State Street Corp1.51%1,507,298$7.46MInstitution
Morgan Stanley1.42%1,414,061$7.00MInstitution

1 of 3

AQST vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AQST47.76%7.74%Net SellingNet Selling
ETON61.71%33.14%Net SellingNet Selling
EOLS76.74%23.26%Net SellingNet Buying
EBS44.23%55.77%Net SellingNet Selling
ESPR48.72%20.33%Net SellingNet Selling
View Top Pharmaceutical Stocks

Aquestive Therapeutics Stock Ownership FAQ

Who owns Aquestive Therapeutics?

Aquestive Therapeutics (NASDAQ: AQST) is owned by 47.76% institutional shareholders, 7.74% Aquestive Therapeutics insiders, and 44.50% retail investors. Douglas K. Bratton is the largest individual Aquestive Therapeutics shareholder, owning 1.96M shares representing 1.97% of the company. Douglas K. Bratton's Aquestive Therapeutics shares are currently valued at $9.92M.

If you're new to stock investing, here's how to buy Aquestive Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.